Work

Abstract 3347: Developing a prognostic biomarker of EGFR/RAS/SIAH pathway activation/inactivation following neoadjuvant chemotherapy to risk stratify patients, detect racial disparity, and predict relapse and survival in triple-negative breast cancer in Hampton Roads, Virginia

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-3347

Authors: Zachary Bouker, Amy H. Tang, Claire B. Piatak, Taylor N. Drake, Caroline D. Lee, Emily L. Breeding, Janet S. Winston, Billur Samli, Rick J. Jansen, Michael Danso, Richard A. Hoefer

Institutions: Eastern Virginia Medical School, Virginia Oncology Associates

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDGs: Good health and well-being, Reduced inequalities

Open Access status: closed

OpenAlex ID: W4409689700

Cites:

Cited by:

Related to: 10